Clover Biopharmaceuticals, Ltd. funding
Clover Biopharmaceuticals, Ltd., a biotechnology company based in Chengdu, China, filed a Form D with the SEC on April 29, 2026 and reported $3.6M raised.
Amount raised$3.6M
Offering size$3.6M
Filed with the SECApril 29, 2026
First saleMarch 27, 2026
IndustryBiotechnology
SecuritiesEquity, Options or warrants
LocationChengdu, China
FoundedMore than 5 years ago
Entity typeCorporation
Investors so far9
Minimum investment—
Revenue rangeDecline to Disclose
View the original Form D on SEC EDGAR ↗ · All rounds filed Apr 29
Other health care rounds
Lisata Therapeutics, Inc.$352M · Oct 2BiotechnologyPrecision Neuroscience Corp$250M · Sep 28Other Health CareZai Lab Ltd$250M · Nov 9BiotechnologyAmerican Republic Insurance Co.$95M · Oct 22Health InsuranceBridge To Life Ltd.$82.5M · Oct 21Other Health CareAlpfa Medical, Inc.$80.3M · Sep 28Other Health CareBigHat Biosciences, Inc.$75.1M · Oct 26BiotechnologyTypewriter Therapeutics, Inc.$56.3M · Sep 21Biotechnology